Toshiba America Medical Systems, In.C: FDA filings under this applicant name
FDA lists 146 510(k) clearances under the applicant name “Toshiba America Medical Systems, In.C” (first 1989, latest 2014), across 30 product codes in 4 review panels. Median 510(k) review time under this name: 47 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Canon Medical Systems, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 6 | 146 |
| 2013 | 3 | 127 |
| 2014 | 3 | 108 |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| JAK | System, X-Ray, Tomography, Computed | 35 | 35 |
| IYN | System, Imaging, Pulsed Doppler, Ultrasonic | 22 | 22 |
| JAA | System, X-Ray, Fluoroscopic, Image-Intensified | 13 | 13 |
| LLZ | System, Image Processing, Radiological | 10 | 10 |
| LNH | System, Nuclear Magnetic Resonance Imaging | 10 | 10 |
| ITX | Transducer, Ultrasonic, Diagnostic | 9 | 9 |
| IYO | System, Imaging, Pulsed Echo, Ultrasonic | 9 | 9 |
| KPS | System, Tomography, Computed, Emission | 6 | 6 |
| MQB | Solid State X-Ray Imager (Flat Panel/Digital Imager) | 5 | 5 |
| OWB | Interventional Fluoroscopic X-Ray System | 3 | 3 |
Plus 20 more product codes.
Review panels
- Radiology (143)
- Cardiovascular (1)
- General Hospital (1)
- Neurology (1)
Most recent Toshiba America Medical Systems, In.C 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K141472 | VANTAGE ELAN | LNH | 2014-09-19 | 108 |
| K133553 | KALARE | JAA | 2014-06-13 | 206 |
| K140729 | APLIO ARTIDA, V3.2 | IYN | 2014-05-23 | 60 |
| K132106 | INFINIX ANGIO WORKSTATION W/DTS SOFTWARE | JAA | 2013-11-12 | 127 |
| K131822 | ULTRAEXTEND USWS-900A V2.1 AND V3.1 | LLZ | 2013-07-23 | 33 |
| K123097 | DOSE TRACKING SYSTEM MODEL XIDF-DTS801 | JAA | 2013-02-13 | 134 |
| K122613 | VANTAGE TITAN WITH HELIOS GRADIENT MODEL MRT-1504/US | LNH | 2012-12-13 | 108 |
| K122842 | RADREX-I, SW V4.00 MODEL DRAD-3000E | MQB | 2012-10-09 | 22 |
| K121076 | ULTRAEXTEND FX, ULTRASOUND WORKSTATION PACKAGE | LLZ | 2012-10-09 | 183 |
| K122109 | AQUILION ONE VISION, V4.90 | JAK | 2012-09-21 | 66 |
136 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Toshiba America Medical Systems, In.C.
78 product recalls in 63 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 2 initiated in the last five years. Most often: Toshiba American Medical Systems Inc (47), Toshiba American Med Sys Inc (19), Canon Medical System, USA, INC. (9).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Toshiba America Medical Systems, In.C (a text match, not an official crosswalk):
- C8903 — Magnetic resonance imaging with contrast, breast; unilateral (via LNH)
- C8906 — Magnetic resonance imaging with contrast, breast; bilateral (via LNH)
- C8905 — Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral (via LNH)
- C8908 — Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral (via LNH)
- C8900 — Magnetic resonance angiography with contrast, abdomen (via LNI)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Toshiba America Mri, Inc. (68 510(k)s)
- Toshiba Medical Systems (54 510(k)s)
- Toshiba Medical Systems Corporation, Japan (9 510(k)s)
- Toshiba Medical Systems Coporation, Japan (5 510(k)s)
- Toshiba Medical Systems Coroporation (2 510(k)s)
- Toshiba America Electronic Components, Inc. (1 510(k)s)
- Toshiba Glass Co., Ltd. (1 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Toshiba America Medical Systems, In.C?
FDA lists 146 510(k) clearances under the applicant name “Toshiba America Medical Systems, In.C” (first 1989, latest 2014), across 30 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Toshiba America Medical Systems, In.C?
The median time from FDA receipt to decision across 510(k)s cleared under the name Toshiba America Medical Systems, In.C is 47 days.
Which FDA product codes appear under Toshiba America Medical Systems, In.C?
The most frequent FDA product codes under this applicant name are JAK (System, X-Ray, Tomography, Computed, 35); IYN (System, Imaging, Pulsed Doppler, Ultrasonic, 22); JAA (System, X-Ray, Fluoroscopic, Image-Intensified, 13).
Next steps
- See all 146 Toshiba America Medical Systems, In.C clearances with predicates and recalls
- Run predicate analysis for product code JAK, Toshiba America Medical Systems, In.C's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.